S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Copper Exploration Heating Up (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
Copper Exploration Heating Up (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Copper Exploration Heating Up (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Copper Exploration Heating Up (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
Copper Exploration Heating Up (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Copper Exploration Heating Up (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Copper Exploration Heating Up (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
Copper Exploration Heating Up (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Copper Exploration Heating Up (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Copper Exploration Heating Up (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
Copper Exploration Heating Up (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Copper Exploration Heating Up (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
NASDAQ:SILK

Silk Road Medical - SILK Stock Forecast, Price & News

$53.25
0.00 (0.00%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$52.52
$54.20
50-Day Range
$40.04
$53.25
52-Week Range
$27.21
$54.20
Volume
551,567 shs
Average Volume
534,357 shs
Market Capitalization
$2.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$47.00

Silk Road Medical MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
11.7% Downside
$47.00 Price Target
Short Interest
Healthy
6.43% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$3.42 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.57) to ($1.40) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.55 out of 5 stars

Medical Sector

964th out of 1,052 stocks

Surgical & Medical Instruments Industry

98th out of 104 stocks

SILK stock logo

About Silk Road Medical (NASDAQ:SILK) Stock

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Stock News Headlines

Silk Road Shares Rise After 3Q Loss Narrows
Silk Road Medical's Earnings: A Preview
Silk Road Medical Reaches Analyst Target Price
Silk Road Medical Announces Pricing of Public Offering
SILK Crosses Above Average Analyst Target
See More Headlines
Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Company Calendar

Last Earnings
11/09/2021
Today
12/02/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SILK
Employees
352
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$47.00
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$38.00
Forecasted Upside/Downside
-11.7%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$-49,810,000.00
Pretax Margin
-45.01%

Debt

Sales & Book Value

Annual Sales
$101.47 million
Book Value
$1.50 per share

Miscellaneous

Free Float
35,203,000
Market Cap
$2.03 billion
Optionable
Not Optionable
Beta
1.27

Key Executives

  • Ms. Erica J. RogersMs. Erica J. Rogers (Age 58)
    Pres, CEO & Director
    Comp: $987.28k
  • Mr. Lucas W. BuchananMr. Lucas W. Buchanan (Age 45)
    CFO & COO
    Comp: $790.27k
  • Mr. Kevin J. Ballinger (Age 49)
    Chief Legal & Corp. Sec.
    Comp: $333
  • Mr. Andrew S. DavisMr. Andrew S. Davis (Age 53)
    Chief Commercial Officer
    Comp: $777.22k
  • Mr. Richard M. RuedyMr. Richard M. Ruedy (Age 55)
    Exec. VP of Clinical, Regulatory Affairs & Quality Assurance
    Comp: $449.68k
  • Ms. Mhairi L. Jones
    VP of Fin. & Accounting
  • Mr. Matthew McCarthy
    VP of Marketing
  • Ms. Alison Highlander
    VP of HR
  • Dr. Sumaira MacDonald
    Exec. Medical Director
  • Dr. William Whealon Ph.D.
    Exec. VP of R&D













SILK Stock - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings
or view top-rated stocks.

What is Silk Road Medical's stock price forecast for 2023?

4 Wall Street analysts have issued 12 month price objectives for Silk Road Medical's shares. Their SILK share price forecasts range from $38.00 to $60.00. On average, they predict the company's share price to reach $47.00 in the next twelve months. This suggests that the stock has a possible downside of 11.7%.
View analysts price targets for SILK
or view top-rated stocks among Wall Street analysts.

How have SILK shares performed in 2022?

Silk Road Medical's stock was trading at $42.61 at the start of the year. Since then, SILK stock has increased by 25.0% and is now trading at $53.25.
View the best growth stocks for 2022 here
.

When is Silk Road Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our SILK earnings forecast
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) released its quarterly earnings data on Tuesday, November, 9th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.31) by $0.09. The firm earned $24.70 million during the quarter, compared to the consensus estimate of $26.03 million. Silk Road Medical had a negative net margin of 45.16% and a negative trailing twelve-month return on equity of 86.73%. During the same quarter in the prior year, the company earned ($0.31) earnings per share.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical updated its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $134.00 million-$137.00 million, compared to the consensus revenue estimate of $130.60 million.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Alliancebernstein L.P. (8.76%), Vanguard Group Inc. (8.38%), Kayne Anderson Rudnick Investment Management LLC (3.69%), State Street Corp (2.14%), Jennison Associates LLC (1.95%) and Ensign Peak Advisors Inc (1.68%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Lucas W Buchanan, Pincus & Co Warburg and Richard Ruedy.
View institutional ownership trends
.

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $53.25.

How much money does Silk Road Medical make?

Silk Road Medical (NASDAQ:SILK) has a market capitalization of $2.03 billion and generates $101.47 million in revenue each year. The company earns $-49,810,000.00 in net income (profit) each year or ($1.63) on an earnings per share basis.

How many employees does Silk Road Medical have?

The company employs 352 workers across the globe.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 12/2/2022 by MarketBeat.com Staff